Back to Results
First PageMeta Content
Pharmacology / Research / Bioethics / Medical ethics / Genetic engineering / Ataluren / Duchenne muscular dystrophy / Placebo / Medicine / Clinical research / Science


Phase 3 Study of Ataluren in Patients with Nonsense Mutation Duchenne Muscular Dystrophy: Frequently Asked Questions What is ataluren? Ataluren (formerly called PTC124®) is an investigational new drug, which means it is
Add to Reading List

Document Date: 2013-11-30 21:08:11

Open Document

File Size: 76,97 KB

Share Result on Facebook

Continent

Europe / /

Country

Poland / Germany / Switzerland / Belgium / Turkey / France / United States / Brazil / Italy / Canada / Australia / United Kingdom / Israel / Sweden / Spain / South Korea / Chile / Czech Republic / /

IndustryTerm

study site / trial protocol / trial site / cellular machinery / /

MedicalCondition

muscular dystrophy / muscle weakness / Nonsense Mutation Duchenne Muscular Dystrophy / disorder / disorders / /

Organization

European Union / /

Position

principal investigator / genetic counselor / /

Product

prednisolone / prednisone / /

Technology

genetic code / genotyping / trial protocol / /

URL

www.ptcbio.com/ataluren_dmd_trial / www.ptcbio.com/ataluren_dmd_trialsites / www.clinicaltrials.gov / /

SocialTag